Eosinophilic Asthma (Benralizumab) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Eosinophilic Asthma (Benralizumab)
Eosinophilic asthma is a severe form of asthma driven by high levels of immune cells called eosinophils, often requiring advanced treatments like benralizumab. While highly effective, these specialized medications can be costly. TheDrugClub provides a practical solution, offering a membership that helps individuals and families access necessary prescriptions at a reduced price, easing the financial burden of managing this challenging condition.
Understanding Eosinophilic Asthma
Eosinophilic asthma is a distinct and often more severe type of asthma. Unlike other forms, it's characterized by an elevated number of eosinophils, a type of white blood cell, in the airways. These cells contribute to significant inflammation, leading to more frequent and severe asthma attacks, persistent shortness of breath, coughing, and wheezing. For many, standard asthma treatments, such as inhaled corticosteroids and bronchodilators, may not be enough to control symptoms effectively, making daily life challenging and increasing the risk of hospitalizations.
Treatment Options, Including Benralizumab
When traditional asthma medications fall short, healthcare providers often look to advanced therapies. Oral corticosteroids can offer temporary relief but come with significant side effects with long-term use. For those with severe eosinophilic asthma, targeted biologic medications have emerged as a
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.